XML 30 R12.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Stockholders' Equity | Stockholders' Equity Equity Incentive Plan Our 2019 Plan provides for the issuance of stock options, RSAs, RSUs and other equity- or cash-based awards to qualified employees, directors and consultants. Stock options granted under our 2019 Plan have a maximum life of 10 years and an exercise price not less than 100% of the fair market value of our common stock on the date of grant. The number of shares of our Class A common stock reserved for issuance under our 2019 Plan will automatically increase on the first day of each fiscal year through and including January 1, 2029, in an amount equal to 5% of the total number of shares of our Class A common stock and our Class B common stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by our board of directors. 188,472,622 shares of our Class A common stock were reserved for future issuance under our 2019 Plan as of September 30, 2025. Stock Option Activity Stock option activity during the nine months ended September 30, 2025, was as follows (in thousands, except per share amounts):
|  | Stock Options Outstanding
| Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term |  | Aggregate Intrinsic Value (1)
|  |  |  |  | (in years) |  |
Outstanding as of December 31, 2024 | 10,390 |  | $ | 17.21 |  |  | 6.2 |  | $ | 122,472 |
Exercised | (1,836) |  | 4.42 |  |  |  |  |
Outstanding as of September 30, 2025 | 8,554 |  | $ | 19.96 |  |  | 6.7 |  | $ | 104,434 |
Exercisable as of September 30, 2025 | 6,415 |  | $ | 19.96 |  |  | 6.7 |  | $ | 78,326 |
(1)We calculate intrinsic value based on the difference between the exercise price of in-the-money-stock options and the fair value of our common stock as of the respective balance sheet date. The total grant-date fair value of stock options vested was $18.9 million for the nine months ended September 30, 2025 and 2024. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2025 and 2024 was $46.7 million and $62.7 million, respectively. Restricted Stock Unit and Restricted Stock Award Activity RSU and RSA activity during the nine months ended September 30, 2025, was as follows (in thousands, except per share amounts):
|  | Restricted Stock Units and Restricted Stock Awards Outstanding
|  | Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2024 | 37,217 |  | $ | 29.33 |
Granted | 30,687 |  | 29.79 |
Released | (21,489) |  | 28.76 |
Forfeited | (4,741) |  | 28.70 |
Outstanding as of September 30, 2025 | 41,674 |  | $ | 30.04 |
During the first quarter of 2025, we granted 572,884 RSUs that vest subject to continued service and a market condition under which the number of RSUs that vest will range from 0% to 200% of the number granted based on our total stockholder return relative to the returns of the companies in the Nasdaq CTA Internet Index over a three-year performance period from January 1, 2025 to December 31, 2027. The weighted-average grant-date fair value of these RSUs was $49.99, which we estimated using a Monte Carlo simulation model with the following assumptions:
| Three Months Ended March 31, 2025 |  |  |  |
Expected term (in years) | 3.0 |  |  |  |
Risk-free interest rate | 4.3 | % |  |  |  |
Expected volatility | 57.3 | % |  |  |  |
Share-Based Compensation Share-based compensation expense during the three and nine months ended September 30, 2025 and 2024, was as follows (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024 |  |
Cost of revenue | $ | 5,173 |  |  | $ | 3,943 |  |  | $ | 14,228 |  |  | $ | 10,668 |  |  |
Research and development | 152,907 |  |  | 138,610 |  |  | 418,328 |  |  | 369,446 |  |  |
Sales and marketing | 40,324 |  |  | 32,389 |  |  | 109,370 |  |  | 88,284 |  |  |
General and administrative | 36,732 |  |  | 33,034 |  |  | 107,870 |  |  | 98,484 |  |  |
Total share-based compensation | $ | 235,136 |  |  | $ | 207,976 |  |  | $ | 649,796 |  |  | $ | 566,882 |  |  |
We recognized income tax benefits on share-based compensation expense of $48.8 million and $134.9 million for the three and nine months ended September 30, 2025, respectively, which are reflected in benefit from income taxes on our condensed consolidated statements of operations. No income tax benefits were recognized for the three and nine months ended September 30, 2024 due to the valuation allowance on our deferred tax assets. As of September 30, 2025, we had $1,164.5 million of unrecognized share-based compensation expense, which we expect to recognize over a weighted-average period of 1.9 years. Stock Repurchase In November 2024, our board of directors authorized a stock repurchase program of up to $2.0 billion of our Class A common stock. Under the stock repurchase program, we are authorized to repurchase, from time-to-time, shares of our Class A common stock through open market purchases, in privately negotiated transactions or in such other manner as permitted by securities law and as determined by management at such time and in such amounts as management may decide. The program does not obligate us to repurchase any specific number of shares and may be modified, suspended or discontinued at any time. The timing, manner, price and amount of any repurchases are determined by management in its discretion and depend on a variety of factors, including legal requirements, price and economic and market conditions. During the nine months ended September 30, 2025, we repurchased and retired 12,180,904 shares of our Class A common stock for an aggregate purchase price of $427.0 million at an average price per share of $35.06. As of September 30, 2025, $1,472.8 million remained available for repurchases under the stock repurchase program.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration